Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Nanite
Nanite is a biotechnology company pioneering the future of genetic drug delivery with its AI-driven platform, SAYER. This platform combines AI-driven polymer design with multiplexed in vivo screening…
Nanite
Nanite is a biotechnology company pioneering the future of genetic drug delivery with its AI-driven platform, SAYER. This platform combines AI-driven polymer design with multiplexed in vivo screening…
TL;DR
Founded: 2021
Headquarters: Boston, Massachusetts
Focus: AI-driven non-viral polymer nanoparticle (PNP) gene delivery
Platform: SAYER (AI-driven polymer design + multiplexed in vivo screening)
Notable investors: Bill & Melinda Gates Foundation; Cystic Fibrosis Foundation; Zetta Venture Partners; Arkitekt Ventures
Company Overview
Problem Domain
Gene therapy delivery — engineering non-viral delivery vectors that are tissue-specific, low-toxicity, and re-dosable.
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
Grant announced May 8, 2024
Seed round reported in 2023
Seed round reported in 2023
Investor Signal
“Funded by philanthropic foundations and early-stage VCs, including the Bill & Melinda Gates Foundation and the Cystic Fibrosis Foundation alongside Zetta Venture Partners and Arkitekt Ventures”